Department of Biological Sciences, University of the Pacific, Stockton, CA 98211, USA.
Department of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Int J Mol Sci. 2020 Aug 9;21(16):5709. doi: 10.3390/ijms21165709.
The Cpi-17 () gene family is an evolutionarily conserved, vertebrate specific group of protein phosphatase 1 (PP1) inhibitors. When phosphorylated, Cpi-17 is a potent inhibitor of myosin phosphatase (MP), a holoenzyme complex of the regulatory subunit Mypt1 and the catalytic subunit PP1. Myosin phosphatase dephosphorylates the regulatory myosin light chain (Mlc2) and promotes actomyosin relaxation, which in turn, regulates numerous cellular processes including smooth muscle contraction, cytokinesis, cell motility, and tumor cell invasion. We analyzed zebrafish homologs of the Cpi-17 family, to better understand the mechanisms of myosin phosphatase regulation. We found single homologs of both Kepi () and Gbpi () in silico, but we detected no expression of these genes during early embryonic development. Cpi-17 () and Phi-1 () each had two duplicate paralogs, ( and ) and ( and ), which were each expressed during early development. The spatial expression pattern of these genes has diverged, with and expressed primarily in smooth muscle and skeletal muscle, respectively, while and are primarily expressed in neural tissue. We observed that, in in vitro and heterologous cellular systems, the Cpi-17 paralogs both acted as potent myosin phosphatase inhibitors, and were indistinguishable from one another. In contrast, the two Phi-1 paralogs displayed weak myosin phosphatase inhibitory activity in vitro, and did not alter myosin phosphorylation in cells. Through deletion and chimeric analysis, we identified that the difference in specificity for myosin phosphatase between Cpi-17 and Phi-1 was encoded by the highly conserved PHIN (phosphatase holoenzyme inhibitory) domain, and not the more divergent N- and C- termini. We also showed that either Cpi-17 paralog can rescue the knockdown phenotype, but neither Phi-1 paralog could do so. Thus, we provide new evidence about the biochemical and developmental distinctions of the zebrafish Cpi-17 protein family.
CPI-17()基因家族是一个进化上保守的、脊椎动物特异性的蛋白磷酸酶 1(PP1)抑制剂家族。当 Cpi-17 被磷酸化时,它是肌球蛋白磷酸酶(MP)的有效抑制剂,MP 是由调节亚基 Mypt1 和催化亚基 PP1 组成的全酶复合物。肌球蛋白磷酸酶使调节性肌球蛋白轻链(Mlc2)去磷酸化,促进肌球蛋白和肌动蛋白松弛,从而调节许多细胞过程,包括平滑肌收缩、胞质分裂、细胞运动和肿瘤细胞侵袭。我们分析了斑马鱼 Cpi-17 家族的同源物,以更好地理解肌球蛋白磷酸酶调节的机制。我们在计算机上发现了 Kepi()和 Gbpi()的单一同源物,但在早期胚胎发育过程中没有检测到这些基因的表达。Cpi-17()和 Phi-1()各有两个重复的旁系同源物()和(),它们在早期发育过程中均有表达。这些基因的空间表达模式已经分化,和主要在平滑肌和骨骼肌中表达,而和主要在神经组织中表达。我们观察到,在体外和异源细胞系统中,Cpi-17 同源物均作为有效的肌球蛋白磷酸酶抑制剂,彼此之间没有区别。相比之下,在体外,Phi-1 的两个旁系同源物显示出较弱的肌球蛋白磷酸酶抑制活性,并且不能改变细胞中的肌球蛋白磷酸化。通过缺失和嵌合分析,我们确定 Cpi-17 和 Phi-1 对肌球蛋白磷酸酶的特异性差异是由高度保守的 PHIN(磷酸酶全酶抑制)结构域编码的,而不是由更具差异性的 N-和 C-末端编码的。我们还表明,Cpi-17 的任何一个旁系同源物都可以挽救敲低表型,但 Phi-1 的旁系同源物都不能。因此,我们提供了关于斑马鱼 Cpi-17 蛋白家族的生化和发育差异的新证据。